UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 418

Sortiert nach

Measuring the cost of a pediatric vaccine administration in the UK

Vaccine, 2018-01, Vol.36 (2), p.237-242

2018

Volltextzugriff (PDF)

Usability of daily SF36 questionnaires to capture the QALD variation experienced after vaccination with AS03A-adjuvanted monovalent influenza A (H5N1) vaccine in a safety and tolerability study

Health and quality of life outcomes, 2019-05, Vol.17 (1), p.80-80, Article 80

2019

Volltextzugriff (PDF)

Allocating Vaccine Funds for Pneumococcal Vaccination of Infants and Older Adults: A Method for Strategic Evaluation in the Netherlands

Value in health, 2014-11, Vol.17 (7), p.A676-A676

2014

Volltextzugriff (PDF)

EE595 Did We Follow the Right Approach in Economic Evaluations by Discounting Health Gain?

Value in health, 2022-12, Vol.25 (12), p.S172-S172

2022

Volltextzugriff (PDF)

Usability of daily SF36 questionnaires to capture the QALD variation experienced after vaccination with AS03 A -adjuvanted monovalent influenza A (H5N1) vaccine in a safety and tolerability study

Health and quality of life outcomes, 2019-05, Vol.17 (1), p.80

2019

Volltextzugriff (PDF)

Improvement in hospital Quality of Care (QoC) after the introduction of rotavirus vaccination: An evaluation study in Belgium

Human vaccines & immunotherapeutics, 2015-09, Vol.11 (9), p.2266-2273

2015

Volltextzugriff (PDF)

Development of a Survey to Quantify Parents' Priorities for Vaccinating Children Against Rotavirus

Value in health, 2014-11, Vol.17 (7), p.A681-A681

2014

Volltextzugriff (PDF)

Health Economic Model On the Costs and Effects of Rotavirus Vaccination in Romania

Value in health, 2014-11, Vol.17 (7), p.A509-A509

2014

Volltextzugriff (PDF)

Measuring and Observing Positive And Negative Externalities Caused By Vaccines: Do We Have The Right Assessment Approach Available?

Value in health, 2014-11, Vol.17 (7), p.A450-A450

2014

Volltextzugriff (PDF)

Workflow Mapping for Paediatric Vaccination Process in the United Kingdom (Uk): A Precursor of A Time and Motion (T&M) Study

Value in health, 2014-11, Vol.17 (7), p.A582-A582

2014

Volltextzugriff (PDF)

An Analysis of How Not to Use Cost-Effectiveness Analysis for Price-Setting

Value in health, 2013-11, Vol.16 (7), p.A616-A616

2013

Volltextzugriff (PDF)

Informing the Affordability of Vaccines with Different Health Care Financing Mechanisms

Value in health, 2013-11, Vol.16 (7), p.A473-A473

2013

Volltextzugriff (PDF)

Cost-effectiveness of infant vaccination with RIX4414 (Rotarix™) in the UK

Vaccine, 2009-07, Vol.27 (33), p.4520-4528

2009

Volltextzugriff (PDF)

Reduction In Absenteeism On The Work Floor After Introduction Of Rotavirus Vaccination: A Case-Study Among The Administrative Personnel Of The City Of Antwerp

Value in health, 2014-05, Vol.17 (3), p.A162-A162

2014

Volltextzugriff (PDF)

How Do Decision Makers in Europe Value Other Economic Evaluation Tools Than Cost-Effectiveness Analysis for Vaccines?

Value in health, 2014-11, Vol.17 (7), p.A675-A676

2014

Volltextzugriff (PDF)

Cost-effectiveness of Universal Paediatric Rotavirus Vaccination with RIX4414 in Greece

Value in health, 2013-11, Vol.16 (7), p.A333-A333

2013

Volltextzugriff (PDF)

Can a Multi-Criteria Decision (MCD) Optimisation Model Help Decision Makers in the Optimal Selection of Vaccines When Expanding Their Universal Mass Vaccination Programme? The Case of Poland

Value in health, 2013-11, Vol.16 (7), p.A615-A615

2013

Volltextzugriff (PDF)

VA4 Found the Missing Link? How to Relate Cohort Models to Observed Population Data

Value in health, 2012-11, Vol.15 (7), p.A288-A288

2012

Volltextzugriff (PDF)

PIN10 Fourth Year Post-Rotavirus Vaccination in Belgium: Decrease of Rotavirus-Positive Stool Samples in Hospitalised Children

Value in health, 2012-11, Vol.15 (7), p.A386-A386

2012

Volltextzugriff (PDF)

PRM170 Optimizing Public Health Decision Over Time: A Dynamic Budget Optimization Model With Multiple Criteria Decision Making

Value in health, 2012-11, Vol.15 (7), p.A491-A491

2012

Volltextzugriff (PDF)

PHP102 From Value to Price: What Should Be the Path for Orphan Drugs?

Value in health, 2012-06, Vol.15 (4), p.A31-A31

2012

Volltextzugriff (PDF)

CO4 Cost-Effectiveness Analysis - Appropriate for All Situations?

Value in health, 2012-06, Vol.15 (4), p.A2-A2

2012

Volltextzugriff (PDF)

PMU2 Will Vaccinating an Aging Population Lead to Good Return on Investment?

Value in health regional issues, 2020-09, Vol.22, p.S68-S68

2020

Volltextzugriff (PDF)

PRM161 A Paradigm Shift in Health Economic Evaluations for Developing Countries - Optimization Modelling for Assessing Which Mix of Malaria Prevention Strategies Achieves a Defined Public Health Target at the Lowest Budget

Value in health, 2012-11, Vol.15 (7), p.A490-A490

2012

Volltextzugriff (PDF)

IN3 Translating Outcomes from a Dynamic Transmission Model for Varicella Vaccination to Cost-Effectiveness Estimates: The Impact of Different Analytic Approaches on the Results

Value in health, 2012-06, Vol.15 (4), p.A10-A10

2012

Volltextzugriff (PDF)

1 – 25 von 418

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(363)
Mit Volltextzugriff
(366)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(206)
Life Sciences & Biomedicine
(163)
Humans
(107)
Animals
(99)
Male
(84)
Biological And Medical Sciences
(83)
Neurosciences & Neurology
(67)
Internal Medicine
(54)
Neurosciences
(53)
Female
(51)
Rats
(48)
Fundamental And Applied Biological Sciences. Psychology
(45)
Medical Sciences
(40)
Middle Aged
(30)
Technology
(28)
Aged
(26)
In Situ Hybridization
(26)
Rats, Sprague-Dawley
(26)
Adult
(22)
Biochemistry & Molecular Biology
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Measuring the cost of a pediatric vaccine administration in the UK

Usability of daily SF36 questionnaires to capture the QALD variation experienced after vaccination with AS03A-adjuvanted monovalent influenza A (H5N1) vaccine in a safety and tolerability study

Allocating Vaccine Funds for Pneumococcal Vaccination of Infants and Older Adults: A Method for Strategic Evaluation in the Netherlands

EE595 Did We Follow the Right Approach in Economic Evaluations by Discounting Health Gain?

Usability of daily SF36 questionnaires to capture the QALD variation experienced after vaccination with AS03 A -adjuvanted monovalent influenza A (H5N1) vaccine in a safety and tolerability study

Improvement in hospital Quality of Care (QoC) after the introduction of rotavirus vaccination: An evaluation study in Belgium

Development of a Survey to Quantify Parents' Priorities for Vaccinating Children Against Rotavirus

Health Economic Model On the Costs and Effects of Rotavirus Vaccination in Romania

Measuring and Observing Positive And Negative Externalities Caused By Vaccines: Do We Have The Right Assessment Approach Available?

Workflow Mapping for Paediatric Vaccination Process in the United Kingdom (Uk): A Precursor of A Time and Motion (T&M) Study

An Analysis of How Not to Use Cost-Effectiveness Analysis for Price-Setting

Informing the Affordability of Vaccines with Different Health Care Financing Mechanisms

Cost-effectiveness of infant vaccination with RIX4414 (Rotarix™) in the UK

Reduction In Absenteeism On The Work Floor After Introduction Of Rotavirus Vaccination: A Case-Study Among The Administrative Personnel Of The City Of Antwerp

How Do Decision Makers in Europe Value Other Economic Evaluation Tools Than Cost-Effectiveness Analysis for Vaccines?

Cost-effectiveness of Universal Paediatric Rotavirus Vaccination with RIX4414 in Greece

Can a Multi-Criteria Decision (MCD) Optimisation Model Help Decision Makers in the Optimal Selection of Vaccines When Expanding Their Universal Mass Vaccination Programme? The Case of Poland

VA4 Found the Missing Link? How to Relate Cohort Models to Observed Population Data

PIN10 Fourth Year Post-Rotavirus Vaccination in Belgium: Decrease of Rotavirus-Positive Stool Samples in Hospitalised Children

PRM170 Optimizing Public Health Decision Over Time: A Dynamic Budget Optimization Model With Multiple Criteria Decision Making

PHP102 From Value to Price: What Should Be the Path for Orphan Drugs?

CO4 Cost-Effectiveness Analysis - Appropriate for All Situations?

PMU2 Will Vaccinating an Aging Population Lead to Good Return on Investment?

PRM161 A Paradigm Shift in Health Economic Evaluations for Developing Countries - Optimization Modelling for Assessing Which Mix of Malaria Prevention Strategies Achieves a Defined Public Health Target at the Lowest Budget

IN3 Translating Outcomes from a Dynamic Transmission Model for Varicella Vaccination to Cost-Effectiveness Estimates: The Impact of Different Analytic Approaches on the Results

Suchergebnisse filtern